Skip to content
See how we’re building brain interfaces to enable silent speech

Company

Welcome, David McMullen!

Like so many of us at Neuralink, David McMullen can trace his lifelong passion for brain-computer interfaces back to a single, clarifying moment. As an undergraduate at Duke University, he read a magazine article that fundamentally changed how he saw the future: a world in which this technology could restore independence to millions of people. The only problem was the technology was still decades away.

So he decided to do something about it.

Fueled by curiosity, David walked into one of Duke’s top neuroscience labs to see the state of the art for himself. There he worked alongside some of the field’s leading minds—including Joey O’Doherty, who’s now at Neuralink too. He spent the next several years splitting his time between academia, medical training, and the lab, contributing to several first-in-human BCI devices—including a cutting-edge system that enabled a person to control two robotic arms simultaneously using only their brain signals.

David went on to serve at DARPA, the NIH, and the FDA, where he helped shape the modern BCI ecosystem across research, regulation, and policy. Over the years, it became apparent that neural interfaces were finally reaching the point where, with the right technical and operational leadership, they could truly help millions of people in need. David realized that the highest impact move he could make now toward the vision he’d carried since that magazine article was to join a team building a leading BCI device itself.

At Neuralink, David will lead Medical Affairs, bridging our clinical, research, and regulatory efforts with the real-world needs of patients, clinicians, and the entire neuromodulation community. His mission: to ensure our technology is not just groundbreaking, but genuinely useful, and that it reaches people responsibly and at scale.

“This role combines scientific rigor, direct patient impact, and the chance to move the entire field of BCI forward,” David said. “My highest calling has always been to get safe and effective devices to the people who need them most. Neuralink is one of the very few places where that mission feels not just possible, but urgent.”

David’s first day at Neuralink will be December 22, 2025. We couldn’t be more excited that David is choosing to bring his talent and conviction here.